NCT00947102Unknown不适用
Observational Study - Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Tubular Carcinoma
Blood Transfusion Centre of Slovenia1 个研究点 分布在 1 个国家开始时间: 2009年2月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 试验地点
- 1
研究概览
简要总结
Observational study of influence of gemcitabine treatment on serological and immunological status and gene expression profile in patients with pancreatic tubular carcinoma after tumor resection.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 30 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •ECOG performance status 0-2 at the time of inclusion
- •Following R0 or R1 pancreatic tubular adenocarcinoma resection
排除标准
- •Pregnancy
- •Serious comorbidity
研究者
研究点 (1)
Loading locations...
相似试验
暂停
1 期
Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct CancerBile Duct CancerNCT00624182Akita University Hospital9
已完成
1 期
Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian CancerRecurrent Ovarian CancerNCT01639885Leiden University Medical Center15
已完成
1 期
Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic CancerPancreatic CancerNCT00622622Wakayama Medical University21
已完成
2 期
Phase II/III study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemotherapy for resectable pancreatic cancer (Prep-02/JSAP-05)JPRN-UMIN000009634Study group of preoperative therapy for pancreatic cancer (PREP)/Japanese Study Group of Adjuvant Therapy for pancreatic Cancer (JSAP)364
已完成
2 期
A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal CancerMetastatic Colorectal CancerNCT01472770Vejle Hospital49